Laman UtamaABUS • NASDAQ
add
Arbutus Biopharma Corp
$3.53
Selepas Waktu Dagangan:(1.98%)+0.070
$3.60
Tutup: 13 Jun, 8:00:00 PTG GMT-4 · USD · NASDAQ · Penafian
Tutup sebelumnya
$3.58
Julat hari
$3.49 - $3.60
Julat tahun
$2.71 - $4.72
Permodalan pasaran
676.09J USD
Bilangan Purata
754.57K
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Berita pasaran
FinanceFeeds
2 hari lalu
S&P 500 Menembus Aliran Naik Di Tengah Ketegangan Timur Tengah yang Meningkat
1.79%
1.13%
1.20%
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Mac 2025info | Perubahan T/T |
|---|---|---|
Hasil | 1.76J | 15.14% |
Perbelanjaan pengendalian | 5.83J | 9.79% |
Pendapatan bersih | -24.53J | -37.21% |
Margin untung bersih | -1.39K | -19.16% |
Pendapatan bagi setiap syer | -0.18 | -32.01% |
EBITDA | -12.70J | 32.56% |
Kadar cukai berkesan | — | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Mac 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 112.71J | -12.79% |
Jumlah aset | 117.01J | -22.14% |
Jumlah liabiliti | 37.85J | 6.17% |
Jumlah ekuiti | 79.16J | — |
Syer tertunggak | 191.53J | — |
Harga kepada buku | 8.73 | — |
Pulangan pada aset | -26.19% | — |
Pulangan pada modal | -34.60% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Mac 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -24.53J | -37.21% |
Tunai daripada operasi | -13.39J | 30.60% |
Tunai daripada pelaburan | 11.35J | -2.95% |
Tunai daripada pembiayaan | 2.78J | -88.60% |
Perubahan bersih dalam tunai | 746.00K | -95.56% |
Aliran tunai bebas | 59.62K | 100.47% |
Perihal
Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection.
It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007. Wikipedia
Diasaskan
2007
Tapak web
Pekerja
44
